IL6 and Cognitive impairment: Although some of the selected studies observed that patients on chemotherapy experienced cognitive impairment and dysregulation in pro-inflammatory cytokines of IL-1β, IL-6 and TNF-α, there is limited evidence to suggest that there is an association between the severity of cognitive impairment and cytokine dysregulation.